Clinical Trials Browser

Completed × Cholangiocarcinoma × olaparib × Clear all

NCT04306367 2025-02-17

Study of Pembrolizumab and Olaparib in Bile Duct Cancer

Phase 2 Completed

14 enrolled 13 charts

Gastrointestinal

Cholangiocarcinoma